Aberdare Ventures
Venture Capital
Active
San Francisco, United States
74
18M
38
2.96
6
0.49
21
- Stages of investment
- Areas of investment
Summary
In 1999 was created Aberdare Ventures, which is appeared as VC. The leading representative office of defined VC is situated in the San Francisco. The fund was located in North America if to be more exact in United States.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Aberdare Ventures, startups are often financed by New Leaf Venture Partners, Versant Ventures, InterWest Partners. The meaningful sponsors for the fund in investment in the same round are New Leaf Venture Partners, Venrock, InterWest Partners. In the next rounds fund is usually obtained by Venrock, Novartis Venture Fund, New Enterprise Associates.
The higher amount of exits for fund were in 2018. The usual things for fund are deals in the range of 10 - 50 millions dollars. Opposing the other organizations, this Aberdare Ventures works on 5 percentage points less the average amount of lead investments. The real fund results show that this VC is 10 percentage points less often commits exit comparing to other companies. The important activity for fund was in 2011. The fund is constantly included in 2-6 deals per year.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Anacor Pharmaceutical, Pharmion, Omada Health. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Health Care, Biopharma. The fund has specific favorite in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low.
This organization was formed by Aaron McKethan, Paul Klingenstein. We also calculated 1 valuable employee in our database.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 74
- Lead investments
- 6
- Exits
- 21
- Rounds per year
- 2.96
- Follow on index
- 0.49
- Investments by industry
- Health Care (41)
- Biotechnology (40)
- Pharmaceutical (24)
- Medical (21)
- Medical Device (15) Show 35 more
- Investments by region
-
- United States (71)
- Peak activity year
- 2011
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 17
- Avg. valuation at time of investment
- 282M
- Group Appearance index
- 0.96
- Avg. company exit year
- 10
- Avg. multiplicator
- 4.18
- Strategy success index
- 0.70
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| BeetsDAO | 01 Sep 2021 | Gaming, Blockchain | Seed | 1M | United States, Florida, Miami |
| Idun Pharmaceuticals | 15 Jun 2004 | Biotechnology, Therapeutics, Biopharma | Early Stage Venture | 27M | United States, California, San Diego |
| Kit Check | 01 Oct 2012 | Software, Information Technology, Health Care, Enterprise Software | Seed | 100K | United States, District of Columbia, Washington |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.